Showing results (11-20 of 94) with videos related to
Sort By:
Pageof 10
The Journal of Pathology|September 1, 1989
Osteoclasts are present in the giant cell variant of malignant fibrous histiocytomaA M Flanagan, T J ChambersThe American Journal of Physiology|March 5, 1998
Physiological plasma levels of androgens reduce bone loss in the ovariectomized ratC K Lea, A M FlanaganEndocrinology|January 1, 1992
Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2A M Flanagan, T J ChambersThe Journal of Endocrinology|December 22, 1998
Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780C K Lea, A M FlanaganBone and Mineral|April 1, 1989
Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated boneA M Flanagan, T J ChambersHuman Reproduction (Oxford, England)|November 5, 1999
Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric studyK Clifford, A M Flanagan, L ReganBone|April 29, 1998
Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bonesM Edwards, U Sarma, A M FlanaganCalcified Tissue International|April 1, 1996
Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female ratsC Lea, N Kendall, A M FlanaganCell|June 29, 1990
A novel mediator between activator proteins and the RNA polymerase II transcription apparatusR J Kelleher, P M Flanagan, R D KornbergThe Journal of Biological Chemistry|October 5, 1989
Inhibitor analysis of synapsis by resolvaseP M Flanagan, M C Finn, M A FennewaldPageof 10